Patents
Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
12/2009
12/31/2009US20090325267 Modified xylanases exhibiting increased thermophilicity and alkalophilicity
12/31/2009US20090324605 Interferon alpha antibodies and their uses
12/31/2009US20090321350 Method of growing bacteria for use in wastewater treatment
12/30/2009CN100575482C Novel cytokine zcytor17 ligand
12/29/2009US7638330 Method of promoting the differentiation of staminal cells
12/29/2009US7638327 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with expression of B-cells and immunoglobulins); treatment of cancers, lymphomas, autoimmune diseases related to B-cells
12/29/2009US7638322 vascular endothelial growth factor (VEGF); ischemic heart disease
12/29/2009US7638297 Compositions for protein biosynthetic machinery; orthogonal lysyl-tRNAs, orthogonal lysyl-aminoacyl-tRNA synthetases and orthogonal pairs of lysyl-tRNAs/synthetases which incorporate homoglutamines into proteins are provided in response to four base codon; biosynthesis enzyme; therapeutic use
12/24/2009US20090318537 Silencing of tgf beta type ii receptor expression by sirna
12/23/2009CN100572557C Expression pattern based on tissue culture
12/23/2009CN100572556C Nucleic acid probes and broad-range primers from regions in topoisomerase genes, and methods in which they are used
12/23/2009CN100572533C Saccharomyces cerevisiae yeast strain with improved phytase activity
12/23/2009CN100572390C Inhibitor of stem cell proliferation and uses thereof
12/22/2009US7635677 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with theexpression of B-cells and immunoglobulins); this receptor can be employed in the treatment of cancers, lymphomas, autoimmune diseases related to B-cells
12/17/2009US20090311669 Signal for packaging of influenza virus vectors
12/16/2009CN101602807A Mammalian cytokines, reagent and method thereof
12/16/2009CN100569286C Attenuated strains of vibrio cholerae with freeze-dry type and modified biological security for orally inoculability
12/15/2009US7632984 Modulation of flowering time by the pft1 locus
12/15/2009US7632681 Compositions and methods for propagation of neural progenitor cells
12/08/2009US7629448 Sample suspected of containing the target polynucleotide is contacted with a polycationic multichromophore and a sensor polynucleotide complementary to the target polynucleotide; kits
12/08/2009US7628986 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
12/03/2009US20090298148 Regio- and enantioselective alkane hydroxylation with modified cytochrome p450
12/03/2009US20090298124 Site-specific incorporation of redox active amino acids into proteins
12/02/2009EP2128270A1 Osteoarthritis biomarkers and uses thereof
12/02/2009EP2128248A1 Oligonucleotide compositions with enhanced efficiency
12/02/2009EP1309726B1 Rna sequence-specific mediators of rna interference
12/01/2009US7625717 Provides eukaryotic cells with translation components, e.g., pairs of orthogonal aminoacyl-tRNA synthetases and orthogonal tRNAs and individual components thereof, used in eukaryotic protein biosynthetic machinery to incorporate an unnatural amino acid in a growing polypeptide chain in a eukaryotic cell
11/2009
11/26/2009US20090292112 provide polypeptides inter alia that have been identified as novel proteins with homology to the Mindin family of extracellular matrix proteins (RG1); prostate cancer or benign prostatic hyperplasia, which is alleviated by decreasing the level of RG1 activity
11/25/2009EP1268509B1 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof
11/24/2009US7622564 Monoclonal antibody comprising an antigen binding site that binds specifically to PSCA protein wherein monoclonal antibody comprises the amino acid sequence of the variable heavy chain region and the variable light chain region of antibody secreted by hybridoma assigned A.T.C.C. Accession No.: PTA-6697
11/19/2009US20090286853 Modified oligonucleotides for telomerase inhibition
11/19/2009US20090286687 Method and Compositions for Detection and Enumeration of Genetic Variations
11/18/2009EP1448799B1 Kits and methods of selective nucleic acid isolation
11/17/2009US7620500 Optimization of crossover points for directed evolution
11/17/2009US7618814 Microrna-related nucleic acids and uses thereof
11/17/2009US7618802 Compositions of coronaviruses with a recombination-resistant genome
11/17/2009US7618775 Cells comprise orthogonal aminoacyl-tRNA synthetase and p-acetyl-L-phenylalanine; site-directed mutagenesis; kits
11/17/2009US7618774 Materials and methods for identifying genes and/or agents that alter replicative lifespan
11/11/2009CN100558883C New strains of bifidobacterium having the ability to produce glutamine
11/05/2009US20090275587 Methods of treating ischemic related conditions
11/05/2009US20090274816 Delta-15 desaturase genes suitable for increasing levels of omega-3 fatty acids
11/05/2009US20090274717 Genes and proteins, and their use
11/05/2009US20090274699 Ul16 binding protein 4
11/04/2009EP1668114B1 Polypeptide display libraries and methods of making and using thereof
11/03/2009US7612442 Semiconductor device
11/03/2009US7612019 Bioassay; membrane proteins; fusion proteins; capable of binding c-reactive protein; flow cytometry
11/03/2009US7611701 Generation of granulate for use in animal feeds; prepare enzyme, water and solid support, recover granules and dry
11/03/2009US7610942 Cell suspension rotating fluidic pump
10/2009
10/29/2009US20090270485 Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site
10/29/2009US20090270323 Methods for treatment of insulin-like growth factor-1 (igf-1) deficiency
10/29/2009US20090269828 Acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous yeasts
10/28/2009EP1497438B1 Means and methods for the production of adenovirus vectors
10/28/2009EP0983361B1 Bacterial pheromones and uses therefor
10/28/2009EP0651793B1 Dna sequences used in the production of recombinant human bssl/cel in transgenic non-human mammals, and the produced bssl/cel used in infant formulas
10/27/2009US7608591 Targeted delivery to legumain-expressing cells
10/27/2009US7608423 Expanding the eukaryotic genetic code
10/27/2009CA2146145C Immunogenic meningococcal lps and outer membrane vesicles and vaccine therefrom
10/22/2009US20090264381 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer
10/22/2009US20090264362 Influenza virus inhibiting peptides
10/22/2009US20090264311 Thermostable peroxide-driven cytochrome P450 oxygenase variants and methods of use
10/22/2009US20090263868 Nucleotide Compositions Comprising Photocleavable Markers And Methods Of Preparation Thereof
10/22/2009US20090263386 Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency
10/22/2009US20090263379 Monoclonal antibodies for inhibition of laminin-8 expression to inhibit human gliomas
10/21/2009EP2110379A2 Mammalian sphingosine kinase type 2 isoforms, and uses thereof
10/21/2009EP1654378B1 Methods for chemically synthesizing immunoglobulin chimeric proteins
10/21/2009CN101560502A Herpes virus strains for gene therapy
10/20/2009US7605308 Regulation of quinolate phosphoribosyl transferase expression
10/20/2009US7604995 Compositions, kits, and methods for stimulation of homologous recombination
10/14/2009EP1677606B1 Angiogensis models using nestin-expressing stem cells to image nascent blood vessels
10/13/2009US7601806 isolated polypeptide encoded by an isolated nucleic acid molecule as antitumor biodrugs; modulation of chemokine, cytokine expression
10/13/2009US7601750 Hydroxyalkylindole derivatives as anticancer agents; methyl [3-hydroxymethyl-2-(1-pentyl)-1-(2-phenylethyl)-5-methyl]indole-6-carboxylate, for example
10/13/2009US7601505 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
10/13/2009US7601492 detecting a polynucleotide-polypeptide interaction domain in a genome of an organism, involves immunoprecipitating polynucleotides linked to a polypeptide; identify various functional DNA elements embedded in the human genome
10/13/2009US7601491 Pretreatment method for extraction of nucleic acid from biological samples and kits therefor
10/07/2009CN101550190A An anti-il-12 antibody, a composition, a method and the function
10/06/2009US7598348 Adiponectin receptor variant, AdipoR2v2
10/01/2009US20090246859 Methods and Compositions for Purification of Nucleic Acid from a Host Cell
10/01/2009US20090246193 Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions
09/2009
09/30/2009EP2105504A2 Genes and proteins, and their use
09/29/2009US7595379 Monoclonal antibody comprising an antigen binding site that binds specifically to PSCA protein wherein monoclonal antibody comprises the amino acid sequence of the variable heavy chain region and the variable light chain region of antibody secreted by hybridoma assigned A.T.C.C. Accession No.: PTA-6697
09/29/2009US7595194 Isolation of mammalian CNS glial-restricted precursor cells
09/29/2009US7595158 Bcl2L12 polypeptide activators and inhibitors
09/24/2009US20090240038 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
09/24/2009US20090238874 Biomimetic composition reinforced by a polyelectrolytic complex of hyaluronic acid and chitosan
09/24/2009US20090238821 Humanized antibodies that sequester amyloid beta peptide
09/24/2009US20090238757 Methods and Compositions for Administering Therapeutic and Diagnostic Agents
09/23/2009CN101538551A A device
09/22/2009US7592434 Pectate lyases, nucleic encoding them and methods for making and using them
09/22/2009US7592171 Vibrio cholerae with improved biological safety features in freeze dried form
09/22/2009US7592149 Can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 184P1E2 can be used in active or passive immunization
09/17/2009US20090233347 Production of polyunsaturated fatty acids in oleaginous yeasts
09/17/2009US20090233346 Production of polyunsaturated fatty acids in oleaginous yeasts
09/17/2009US20090233335 Variant humicola Grisea CBH1.1
09/17/2009US20090233333 Methods for preventing gluconoylation of proteins
09/17/2009US20090232805 Methods of inhibiting receptor tyrosine kinases with an extracellular antagonist and an intracellular antagonist
09/16/2009EP1478656B1 Oligonucleotide compositions with enhanced efficiency
09/16/2009CN101532046A Site-specific incorporation of redox active amino acids into proteins
09/16/2009CN100540657C Endothelial cells derived from primate embryonic stem cells
09/15/2009US7589174 GRP94-based compositions and methods of use thereof
09/15/2009CA2136859C Use of genetic markers to diagnose familial dysautonomia
1 ... 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 ... 100